Cargando…

Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats

Atrophic maxillary ridges present a challenge in the field of oral implantology. Autologous bone is still considered the gold standard grafting material, but the increased morbidity and surgical complications represent a major drawback for its use. The aim of this study was to assess the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Deluiz, Daniel, Delcroix, Gaëtan J.-R., D’Ippolito, Gianluca, Grau-Monge, Cristina, Bonnin-Marquez, Andrea, Reiner, Teresita, Tinoco, Eduardo M. B., Amadeu, Thaís, Pires, Fabio R., Schiller, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694159/
https://www.ncbi.nlm.nih.gov/pubmed/31413279
http://dx.doi.org/10.1038/s41598-019-48236-8
_version_ 1783443790042759168
author Deluiz, Daniel
Delcroix, Gaëtan J.-R.
D’Ippolito, Gianluca
Grau-Monge, Cristina
Bonnin-Marquez, Andrea
Reiner, Teresita
Tinoco, Eduardo M. B.
Amadeu, Thaís
Pires, Fabio R.
Schiller, Paul C.
author_facet Deluiz, Daniel
Delcroix, Gaëtan J.-R.
D’Ippolito, Gianluca
Grau-Monge, Cristina
Bonnin-Marquez, Andrea
Reiner, Teresita
Tinoco, Eduardo M. B.
Amadeu, Thaís
Pires, Fabio R.
Schiller, Paul C.
author_sort Deluiz, Daniel
collection PubMed
description Atrophic maxillary ridges present a challenge in the field of oral implantology. Autologous bone is still considered the gold standard grafting material, but the increased morbidity and surgical complications represent a major drawback for its use. The aim of this study was to assess the efficacy of an off-the-shelf cell-seeded bone biomaterial for mandibular bone augmentation, compared to its acellular counterpart. We used a rat model to test the osteogenic properties of bone marrow-derived mesenchymal stromal cells (MSCs)-seeded bone microparticles compared to acellular bone microparticles alone. Rats were euthanized at 4 and 8 weeks, and results analyzed using micro-CT imaging, histology (H&E, Masson’s Trichrome), histomorphometry and immunohistology (Tartrate-Resistant Acid Phosphatase-TRAP, Osteocalcin and human specific anti-mitochondria antibodies). Micro-CT analysis demonstrated that the cell-seeded biomaterial achieved significantly more bone volume formation at 4 weeks (22.75 ± 2.25 mm(3) vs 12.34 ± 2.91 mm(3), p = 0.016) and at 8 weeks (64.95 ± 5.41 mm(3) vs 42.73 ± 10.58 mm(3), p = 0.029), compared to the acellular bone microparticles. Histology confirmed that the cell-seeded biomaterial was almost completely substituted at 8 weeks, in opposition to the acellular biomaterial group. Immunohistochemical analysis showed a significantly higher number of TRAP and Osteocalcin positive cells at 4 weeks in the cell-seeded group compared to the acellular group, thereby demonstrating a higher rate of bone remodeling in the presence of MSCs. The grafted human cells remained viable and were detected up to at least 8 weeks, as observed using the human specific anti-mitochondria antibody. This off-the-shelf material available in unlimited quantities could therefore represent a significant advance in the field of mandibular bone augmentation by providing a larger volume of new bone formation in a shorter time.
format Online
Article
Text
id pubmed-6694159
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-66941592019-08-19 Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats Deluiz, Daniel Delcroix, Gaëtan J.-R. D’Ippolito, Gianluca Grau-Monge, Cristina Bonnin-Marquez, Andrea Reiner, Teresita Tinoco, Eduardo M. B. Amadeu, Thaís Pires, Fabio R. Schiller, Paul C. Sci Rep Article Atrophic maxillary ridges present a challenge in the field of oral implantology. Autologous bone is still considered the gold standard grafting material, but the increased morbidity and surgical complications represent a major drawback for its use. The aim of this study was to assess the efficacy of an off-the-shelf cell-seeded bone biomaterial for mandibular bone augmentation, compared to its acellular counterpart. We used a rat model to test the osteogenic properties of bone marrow-derived mesenchymal stromal cells (MSCs)-seeded bone microparticles compared to acellular bone microparticles alone. Rats were euthanized at 4 and 8 weeks, and results analyzed using micro-CT imaging, histology (H&E, Masson’s Trichrome), histomorphometry and immunohistology (Tartrate-Resistant Acid Phosphatase-TRAP, Osteocalcin and human specific anti-mitochondria antibodies). Micro-CT analysis demonstrated that the cell-seeded biomaterial achieved significantly more bone volume formation at 4 weeks (22.75 ± 2.25 mm(3) vs 12.34 ± 2.91 mm(3), p = 0.016) and at 8 weeks (64.95 ± 5.41 mm(3) vs 42.73 ± 10.58 mm(3), p = 0.029), compared to the acellular bone microparticles. Histology confirmed that the cell-seeded biomaterial was almost completely substituted at 8 weeks, in opposition to the acellular biomaterial group. Immunohistochemical analysis showed a significantly higher number of TRAP and Osteocalcin positive cells at 4 weeks in the cell-seeded group compared to the acellular group, thereby demonstrating a higher rate of bone remodeling in the presence of MSCs. The grafted human cells remained viable and were detected up to at least 8 weeks, as observed using the human specific anti-mitochondria antibody. This off-the-shelf material available in unlimited quantities could therefore represent a significant advance in the field of mandibular bone augmentation by providing a larger volume of new bone formation in a shorter time. Nature Publishing Group UK 2019-08-14 /pmc/articles/PMC6694159/ /pubmed/31413279 http://dx.doi.org/10.1038/s41598-019-48236-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Deluiz, Daniel
Delcroix, Gaëtan J.-R.
D’Ippolito, Gianluca
Grau-Monge, Cristina
Bonnin-Marquez, Andrea
Reiner, Teresita
Tinoco, Eduardo M. B.
Amadeu, Thaís
Pires, Fabio R.
Schiller, Paul C.
Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title_full Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title_fullStr Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title_full_unstemmed Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title_short Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats
title_sort human bone marrow-derived mesenchymal stromal cell-seeded bone biomaterial directs fast and superior mandibular bone augmentation in rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694159/
https://www.ncbi.nlm.nih.gov/pubmed/31413279
http://dx.doi.org/10.1038/s41598-019-48236-8
work_keys_str_mv AT deluizdaniel humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT delcroixgaetanjr humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT dippolitogianluca humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT graumongecristina humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT bonninmarquezandrea humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT reinerteresita humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT tinocoeduardomb humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT amadeuthais humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT piresfabior humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats
AT schillerpaulc humanbonemarrowderivedmesenchymalstromalcellseededbonebiomaterialdirectsfastandsuperiormandibularboneaugmentationinrats